Home
About Us
- Team
- Careers
Product & Technology
Investors
News & Events
- Press
Contact

Marathon

October 7, 2019

Therapixel runs against breast cancer

Therapixel ran ODYSSEA marathon to support the fight…

by Neliya Tumbeva

Text

Therapixel is one of the leading French software companies specialising in artificial intelligence applied to medical imaging.

LATEST BLOG NEWS

Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy May 14, 2022
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D May 12, 2022
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis November 28, 2021

RECOMMENDED POSTS

Therapixel secures a €5 million Series A financing and strengthens its governance
Therapixel receives FDA 510(k) clearance for MammoScreen™
Therapixel is now ISO/IEC 27001 certified
Therapixel participates in the Journées Francophones de Radiologie 2020
Scientific Publications

© 2020 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences